Remove patients views-analysis
article thumbnail

The futility of banner ads

World of DTC Marketing

The vast majority of digital advertising is not being viewed at all, yet the drug industry continues to waste money on them. Research has shown that only 35% of digital display ads received views. Display is an incredibly low-effort way to spend your marketing budget, whether trying to reach physicians or patients.

Branding 270
article thumbnail

Deep Dive: Patients and Partnerships 2022

pharmaphorum

The concept of patient centricity has been a key talking point across the healthcare ecosystem for years. Having recognised the tangible benefits that their unique insights and experiences can bring to the table, decision-makers are increasingly seeking new opportunities to partner with patients across a product’s lifecycle.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

True patient-focused research through decentralised and hybrid trials

pharmaphorum

How can pharma improve the patient-centricity of its trials during COVID-19 and beyond? Experts from across the sector give their thoughts on the key approaches and technologies that are driving patient engagement forward. The post True patient-focused research through decentralised and hybrid trials appeared first on.

Trials 105
article thumbnail

The story behind the numbers: how burden of illness studies add value to HTA submissions

pharmaphorum

In a time of increasing cost pressures, limited resource capacity, and heightened demand for new treatments, Health Technology Assessments (HTAs) play a vital role in evaluating whether new interventions will provide sufficient patient benefits to justify the cost to the health service.

52
article thumbnail

The efficacy of Mental Health Apps

pharmaphorum

In their meta-analysis of published studies, the authors found universal deficiencies and concluded that there’s no convincing evidence that app-based interventions deliver meaningful outcomes. I reviewed all 14 meta-analyses included in the study and found the analysis to be accurate, but incomplete. Consistent Standards Matter.

article thumbnail

The Composition and Value of a Portfolio Analysis

Camargo

One of Camargo’s differentiating offerings is the portfolio analysis, a high-level, integrated evaluation of the scientific, medical, regulatory, and commercial viability of each product within a sponsor’s portfolio. Why Conduct a Portfolio Analysis? Each product is unique, and so is the associated development strategy.

article thumbnail

Deep Dive: Market Access

pharmaphorum

Turning words into actions with patient engagement. Boehringer Ingelheim’s Carinne Brouillon tells us how the company co-created its recent Global Patient Partnership Summit with patients. “A Experts from ICON give us their views on the past, present and future of NICE’s standing on the world stage.